Chaldexx - We Care About You - Investor Relations

Our Investors


27th March

The Board of Chaldexx BioPharmaceuticals wishes to reassure our investors that the unfortunate disappearance of Professor DiCanio will not slow the company's progress.

We are deeply concerned for Melissa and will be doing everything we can to help police in Qatar trace her movements in the days before she went missing. However, Melissa has a strong and capable team who will continue with their research at full pace until this stressful time is over.

Andrew Browning, head of Strategy Planning told me "Slack off? We wouldn't dream of it. Melissa means too much to us. When she returns to Chaldexx, we're looking forward to showing her the amazing progress we've made."

Steady words from our colleague there!

Michael Carter, CEO


Chaldexx's private investors span the world. But we're no sell-outs! Sure, we could all make lots of dosh if we let the public buy shares in Chaldexx.

But for Chaldexx, it's not about the money.

We care about improving the health of the human population - from the inside-out.

As we like to say -it's the brain-mind connection, stupid!

51% of the company is still in the hands of the founders:

Founding investors who also sit on the Board of Chaldexx

Dr. Werner Thorens
Chief Operating Officer
Born in Chateau D'Oex, Switzerland, Dr. Thorens was educated at Villa St Jean International School, Fribourg, the University of Geneva and took an MBA at Aquinas College, Oxford. Dr. Thorens previously worked at number of top global pharmaceutical companies.

Professor Melissa DiCanio
Chief Scientific Officer
Born in Houston, Texas, Professor DiCanio began her career at Baylor College of Medicine before moving in 1997 to Oxford University as a Visiting Professor at Aquinas College.
In 1999 she co-founded Chaldexx BioPharmaceuticals PFC. In 2005 Professor DiCanio was awarded the Chaldexx Chair of Molecular Genetic Neuroscience at Cambridge University.
Despite a hectic work schedule that keeps her globe-trotting, Melissa enjoys and excels at skiing. She leads the Chaldexx ski team in a league of top business ski teams. (Photo of Melissa skiing.)

Nik Andreas Rothschild
Chief Finance Officer
Born in London, England, educated at Winchester and New College, Oxford, Nik worked for Baring, Lehman Brothers and JP Morgan before starting his own private equity fund, NAR Innovate which specialises in biotechnology and nanotechnology.

Marius Martineau
Non-Executive Director
Born in Dorchester-upon-Thames, England, Dr. Martineau was educated at Magdalen College School, Oxford and Yale University. He now works at the Peabody Museum of Natural History, Yale University, Connecticut, USA.

Chaldexx People

Salma Allende, Vice President of Regulatory Affairs, HQ Interlaken, Switzerland.  “Today’s regulatory framework is tougher than ever before”, says Salma, “even in a generally pro-business environment such as the Asia Pacific territory.  When the going gets tough, it’s good to know that I have my Chaldexx brothers and sisters solidly behind me.  That’s the Chaldexx difference – we care.”